Detalles de la búsqueda
1.
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).
Cancer Cell Int
; 9: 9, 2009 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19374748
2.
Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cancer Res
; 67(1): 309-17, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17210712
Resultados
1 -
2
de 2
1
Próxima >
>>